Biostar Pharmaceuticals, Inc. (NasdaqCM:BSPM) is on the lookout of acquisitions and recently stated in a filing, "On an on-going basis, we take steps to identify and plan our needs for liquidity and capital resources, to fund our operations and day to day business operations. Our future capital expenditures will include, among others, expanding product lines, research and development capabilities, and making acquisitions as deemed appropriate."